Trial intelligence / Profile preview

Pethidine and dexmedetomidine for prevention of post-cesarean shivering under spinal anesthesia

IRCT20200825048515N5Phase 3Completed

Sponsor
Isfahan University of Medical Sciences
Start
Oct 2020
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, double-blind trial of dexmedetomidine and pethidine in postanesthetic shivering (PAS) (3 arms), sponsored by Isfahan University of Medical Sciences. Primary endpoints: Tympanic temperature, Axillary temperature and 1 more. Started Oct 2020; status: completed.

02

Drugs

dexmedetomidinepethidine
03

Conditions

postanesthetic shivering (PAS)

Beyond the preview

Go deeper on IRCT20200825048515N5.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20200825048515N5.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call